A Food and Drug Administration advisory panel is recommending approval of an over-the-counter, rapid at-home HIV test that would let patients take control of determining their HIV status and could expand the rate of testing.
But some physicians and public health experts say the product, the OraQuick In-Home HIV Test, would allow patients to skip pre- and post-test counseling. It also could hinder efforts to educate patients about practicing safe sex and starting treatment, they said.
My latest. Read the whole shebang.